Author/Authors :
Pavan, Malleshappa Lilavati Hospital and Research Centre - Department of Nephrology, India , Aiyangar, Ashwinikumar Lilavati Hospital and Research Centre - Department of Nephrology, Mumbai , Chaudhari, Anup Lilavati Hospital and Research Centre - Department of Nephrology, Mumbai , Rajputh, Prashanth Lilavati Hospital and Research Centre - Department of Nephrology, Mumbai , Ranganath, Ravi Lilavati Hospital and Research Centre - Department of Nephrology, India , Babulal, Shah Arunkumar Lilavati Hospital and Research Centre - Department of Nephrology, India
Abstract :
Kidney failure is the principal cause of death in scleroderma and accounts for at least 50% of deaths in this disease. Management of scleroderma-related end-stage renal disease requires some form of renal replacement therapy. Survival up to 18 months has been reported in one patient on continuous ambulatory peritoneal dialysis. Surviving for more than 1 year on automated peritoneal dialysis has not been reported. We report a patient with sclerodermarelated end-stage renal disease treated with automated peritoneal dialysis with steady state control of uremia and hypertension at 18 months of follow-up.
